All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
ARWR total return snapshot: ARWR returned +388.83% over the past year and +29.15% YTD, with dividends reinvested. Since Dec. 16, 1993, ARWR is down −97.07% in nominal total return, or −10.27%/yr.
Data ending Wed Jul. 8, 2026
| Thu 1993-12-16💬 to Wed 2026-07-08 |
YTD
Return |
1 Year
Return |
||||
|---|---|---|---|---|---|---|
| ARWR × |
+29.15%
2026-07-08 |
+388.83%
2026-07-08 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Wed 2026-07-08 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ARWR × |
−97.07%
−10.27%/yr |
−3.00%/yr
(R2=0.039) |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Thu 1993-12-16💬 to Wed 2026-07-08 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ARWR × |
$10,000.00
1993-12-16 |
$293.13
2026-07-08 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Year | ARWR |
|---|---|
| 2026 (YTD) | +29.15% |
| 2025 | +253.14% |
| 2024 | −38.56% |
| 2023 | −24.56% |
| 2022 | −38.82% |
| 2021 | −13.59% |
| 2020 | +20.97% |
| 2019 | +410.71% |
| 2018 | +237.50% |
| 2017 | +137.42% |
| 2016 | −74.80% |
| 2015 | −16.67% |
| 2014 | −31.98% |
| 2013 | +407.01% |
| 2012 | −48.93% |
| 2011 | −53.18% |
| 2010 | +68.87% |
| 2009 | −42.39% |
| 2008 | −75.66% |
| 2007 | −13.70% |
| 2006 | +3.06% |
| 2005 | −1.62% |
| 2004 | +232.31% |
| 2003 | +233.33% |
| 2002 | −60.00% |
| 2001 | −76.00% |
| 2000 | +25.00% |
| 1999 | −37.50% |
| 1998 | +60.00% |
| 1997 | −68.00% |
| 1996 | −37.50% |
| 1995 | −80.00% |
| 1994 | −54.55% |
| 1993 | −38.89% |
| Thu 1993-12-16💬 to Wed 2026-07-08 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ARWR × | −97.07% |
−99.96%
2016-12-16 |
||||
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
| Period ending Wed 2026-07-08 |
1
Year |
2
Years |
3
Years |
5
Years |
10
Years |
|
|---|---|---|---|---|---|---|
| ARWR × | +388.83% |
+235.31% +83.12%/yr |
+157.32% +37.03%/yr |
+31.26% +5.59%/yr |
+1,396.34% +31.07%/yr |
|
| Arrowhead Pharmaceuticals Inc NASDAQ Common Stock | ||||||
